Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and 9-(tetrahydro-2-furyl)-adenine

adenosine diphosphate has been researched along with 9-(tetrahydro-2-furyl)-adenine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, JB1
Herbert, JM; Pflieger, AM; Savi, P1
Dangelmaier, C; Daniel, JL; Jin, J; Kim, YB; Kunapuli, SP1
Fälker, K; Lange, D; Presek, P1
Cheng, KT; Huang, Y; Kwan, HY; Ma, Y; Tang, NL; Yao, X; Yu, S1

Other Studies

5 other study(ies) available for adenosine diphosphate and 9-(tetrahydro-2-furyl)-adenine

ArticleYear
Effect of thromboxane synthetase inhibitors on platelet function: enhancement by inhibition of phosphodiesterase.
    Thrombosis research, 1982, Nov-15, Volume: 28, Issue:4

    Topics: Adenine; Adenosine Diphosphate; Collagen; Depression, Chemical; Drug Synergism; Humans; Imidazoles; Oxidoreductases; Phosphodiesterase Inhibitors; Platelet Aggregation; Quinazolines; Thromboxane-A Synthase

1982
cAMP is not an important messenger for ADP-induced platelet aggregation.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:2

    Topics: Adenine; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Animals; Cyclic AMP; Down-Regulation; Female; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Second Messenger Systems

1996
Role of intracellular signaling events in ADP-induced platelet aggregation.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:4

    Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Antimetabolites; Blood Platelets; Dideoxyadenosine; Enzyme Inhibitors; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction

1999
P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Thrombosis and haemostasis, 2005, Volume: 93, Issue:5

    Topics: Adenine; Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Aspirin; Blood Platelets; Collagen; Cyclic AMP; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epinephrine; Epoprostenol; Humans; Membrane Proteins; Oligopeptides; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; Thrombin; Time Factors; Tyrosine

2005
CNGA2 contributes to ATP-induced noncapacitative Ca2+ influx in vascular endothelial cells.
    Journal of vascular research, 2010, Volume: 47, Issue:2

    Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aminoquinolines; Aniline Compounds; Animals; Calcium Channel Blockers; Calcium Signaling; Cattle; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide-Gated Cation Channels; Diltiazem; Endothelial Cells; Enzyme Inhibitors; Imines; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; RNA Interference; Thionucleotides; Time Factors; Transfection; Vasodilation; Xanthenes

2010